Jazz Pharmaceuticals plc Stock
Jazz Pharmaceuticals plc Stock
There is an upward development for Jazz Pharmaceuticals plc compared to yesterday, with an increase of €2.70 (1.190%).
With 50 Buy predictions and not a single Sell prediction Jazz Pharmaceuticals plc is an absolute favorite of our community.
With a target price of 243 € there is a slightly positive potential of 5.88% for Jazz Pharmaceuticals plc compared to the current price of 229.5 €.
Pros and Cons of Jazz Pharmaceuticals plc in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
M***** P*******
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Jazz Pharmaceuticals plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc | 1.190% | 0.532% | 6.529% | 125.896% | 57.064% | 91.797% | 74.865% |
| Repligen Corp. | -0.730% | 1.842% | 6.342% | 26.472% | -7.739% | -16.699% | -39.133% |
| Opko Health Inc. | 1.820% | -24.832% | -11.111% | 6.870% | 2.733% | -36.951% | -62.264% |
| China Traditional Chinese Medicine Co Ltd | 0.000% | 0.000% | 0.000% | -5.172% | 0.917% | -45.813% | -56.000% |
Comments
Jazz Pharmaceuticals (JAZZ) had its price target raised by JPMorgan Chase & Co. from $265.00 to $276.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for JAZZ provided by MarketBeat
Jazz Pharmaceuticals (JAZZ) had its "buy" rating reaffirmed by Deutsche Bank Aktiengesellschaft.
Show more
Ratings data for JAZZ provided by MarketBeat
Jazz Pharmaceuticals (JAZZ) had its "buy" rating reaffirmed by TD Cowen.
Show more
Ratings data for JAZZ provided by MarketBeat